HIV testing — the results that start everything.

Almost everything good that can happen in HIV — treatment that brings the virus to undetectable, a normal life expectancy, protection for the people you love — starts with one result on one test. And almost everything hard about HIV in the U.S. traces back to results that arrive too late, or never arrive.

About 1.2 million people aged 13 and older were living with HIV in the United States at the end of 2022, and roughly 13% — about 158,249 people — did not know it and needed testing.3 Those are not careless people. They are people who were never offered a test, or were offered one in a way that felt like an accusation, or were told a single test years ago had settled the question forever.

Why testing is the door, not the verdict

For a long time HIV testing was framed as a screening of people rather than a screening for a virus — you were asked to place yourself in a category before anyone would hand you a test. That approach missed enormous numbers of people, and taught a generation that asking for a test was a confession.

Public-health guidance moved away from that model two decades ago. In its 2006 revised recommendations, CDC wrote plainly that "in all health-care settings, screening for HIV infection should be performed routinely for all patients aged 13–64 years," and that screening should happen "after the patient is notified that testing will be performed unless the patient declines (opt-out screening)."5 The same document stated that "separate written consent for HIV testing should not be required."5 The point was to make an HIV test as unremarkable as a cholesterol panel.

The U.S. Preventive Services Task Force reached the same place from the evidence side. In June 2019 it issued a Grade A recommendation — its strongest — that "clinicians screen for HIV infection in adolescents and adults aged 15 to 65 years," with a separate Grade A recommendation covering "all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown."66 A Grade A rating also triggers insurance coverage without cost-sharing under the Affordable Care Act.

Two decades of that guidance still have not closed the gap. CDC reports that roughly 1 in 8 people with HIV do not know they have the virus, and that fewer than 40% of U.S. adults had ever been tested as of 2016–2017.2 That is a systems problem, not a personal failing — and if nobody has ever offered you a test, asking for one needs no explanation.

How often, and who benefits from testing more than once

CDC's baseline is one test in a lifetime for everyone 13 to 64. Beyond that, it recommends testing at least once a year for people with any of the following in the period since their last test: being a man who has sex with men; having had anal or vaginal sex with someone living with HIV; having had more than one partner; having shared needles, syringes, or other injection equipment; having exchanged sex for drugs or money; or having been diagnosed with or treated for another sexually transmitted infection, hepatitis, or tuberculosis — and also for people whose partner has done any of those things.1 CDC adds that sexually active gay and bisexual men may benefit from testing every three to six months.1

Read that as a list of situations, not a list of people. The honest version: if you are having sex or sharing injection equipment and cannot remember your last HIV test, it is time for one.

The three kinds of HIV test

There are three types of HIV test in use in the United States, and they look for three different things. Knowing which one you are getting tells you what your result actually covers.1

Window periods — the part nobody explains well

The window period is the time between an exposure to HIV and the point at which a given test can reliably detect it. Test too early and a negative result does not yet mean much. This one concept causes more anxiety, and more false reassurance, than anything else in HIV testing.

CDC publishes the window period for each test type:1

• Antibody test: can usually detect HIV 23 to 90 days after exposure.
• Rapid antigen/antibody test (fingerstick): 18 to 90 days after exposure.
• Laboratory antigen/antibody test (blood from a vein): 18 to 45 days after exposure.
• Nucleic acid test (NAT): 10 to 33 days after exposure.

Those ranges exist because immune systems differ: the lower number is the earliest a test may detect HIV in some people, the upper number the point by which nearly everyone would be detected. That is why a negative test two weeks after a specific exposure is not the end of the conversation, and one at three months generally is.

A note on symptoms: many people have a flu-like illness in the first weeks after acquiring HIV — fever, swollen lymph nodes, rash, aches, headache, mouth ulcers — and many have nothing at all. That is why CDC directs clinicians to explicitly request HIV RNA testing when acute HIV is a concern rather than assuming a negative antibody screen ruled it out.4 "Can we test HIV RNA?" is a legitimate request.

Self-testing at home — what is actually available

Self-testing changed who gets tested: it removes the front desk, the waiting room, the explanation, and the fear of being seen. CDC treats mailed self-tests as core strategy, not novelty.

OraQuick In-Home HIV Test

The OraQuick In-Home HIV Test is a rapid, self-administered over-the-counter test that uses oral fluid to detect antibodies to HIV-1 and HIV-2. You swab your upper and lower gums, place the swab in a vial of developer solution, and read the result after 20 to 40 minutes. The kit includes the test stick, the vial, instructions, two booklets, a disposal bag, and consumer-support phone numbers.12

Its performance is worth understanding honestly. FDA reports sensitivity at approximately 92% — about one false negative per 12 tests in people who do have HIV — and specificity at 99.98%, about one false positive per 5,000 tests in people who do not.12 The window period is roughly three months; FDA notes that per CDC, 97% of people develop detectable antibodies within three months.12 A positive self-test means you may have HIV and requires additional testing in a medical setting; OraQuick's consumer support center operates 24 hours a day and can provide referrals.12

Home Access HIV-1 Test System

The other FDA-approved home option works differently. The Home Access HIV-1 Test System is a home collection kit rather than a home-reading test: you take a fingerstick blood sample, apply drops to specially treated paper, and mail it to a laboratory under an anonymous personal identification number, then call a toll-free number for results and telephone counseling.13

Because a laboratory runs the test, the accuracy profile is different: FDA estimates both sensitivity and specificity above 99.9%, and confirmatory HIV-1 testing is included — all confirmation is completed before any result is released to you.13 Results come about seven business days after shipping (three with the Express version), and the counseling covers prevention, treatment options, and referrals to local doctors.13 Availability of specific kits changes over time, so check current options through GetTested.CDC.gov first.8

Together TakeMeHome — free tests mailed to your door

Together TakeMeHome is a CDC-supported program that mails free HIV self-tests anywhere in the United States, including Puerto Rico. To order you must live in the U.S., be 17 or older, and not have ordered in the past 90 days; eligible orders receive two free self-tests — one to use and one to share.10 People who have already tested positive, and people taking PrEP, can order tests to give away.10 There is no cost, and the support line is 628-899-4662.10

The program aims to distribute at least one million free HIV self-tests over five years, building on an earlier effort that distributed 100,000 in eight months. It is supported by CDC, Emory University, Building Healthy Online Communities, NASTAD, and OraSure Technologies, and its priority audiences are gay and bisexual men — especially Black and Hispanic/Latino men — Black cisgender women, and transgender women.9

The first-year results, published in CDC's Morbidity and Mortality Weekly Report, are the strongest evidence that mailed self-tests reach people the clinic system was missing. Between March 14, 2023 and March 13, 2024, the program distributed 443,813 tests to 219,360 people.11 Among the 169,623 people who answered at least one question at ordering, 67.9% were from priority audiences, 24.1% had never tested for HIV before, another 24.8% had not tested in the past year, and 60.1% were under 35.11

Among 7,893 respondents who used a test themselves and had no previous diagnosis, 151 — 1.9% — reported a positive result, highest among transgender women (3.6%) and Black and Hispanic men who have sex with men (3.0% and 2.9%).11 Positivity ran about twice as high as in all CDC-funded in-person testing.11 Of follow-up respondents, 27.1% gave a test away and 11.7% went on to access additional preventive services, including 4.8% who started PrEP.11

A preliminary-positive result is not a diagnosis

This is the section to read twice — and to send to someone at 11 p.m. staring at a line on a test strip. Every rapid test, every self-test, and every initial laboratory screen produces a preliminary result. CDC's 2006 recommendations put it in one sentence: "Positive rapid HIV test results are preliminary and must be confirmed before the diagnosis of HIV infection is established."5 Confirmation is not a formality — it is a structurally different test looking for different things.

What confirmation actually involves

CDC's recommended laboratory algorithm has a clear sequence.4

1. Start with a laboratory-based HIV-1/HIV-2 antigen/antibody combination assay. If it is repeatedly reactive, move to step 2.
2. Run a laboratory-based HIV-1/HIV-2 antibody differentiation assay. This both confirms the result and distinguishes HIV-1 from HIV-2, which matters for treatment selection.
3. If the screening assay is reactive but the differentiation assay is negative, run HIV RNA testing. CDC states that RNA testing "should be performed on all specimens with reactive immunoassay but negative supplemental antibody test results to determine whether the discordance represents acute HIV infection."

CDC also recommends that everyone with a reactive rapid test be assessed with a laboratory-based antigen/antibody assay.4 If your preliminary positive came from a lab blood draw, the follow-up is usually run on that same sample.1 If it came from a self-test or community rapid test, you will need a blood draw.

Why false positives happen — and why they are rare

Screening tests are tuned to miss as little as possible, so they occasionally flag something that is not HIV — other antibodies, some medical conditions, recent vaccinations, and technical error can all produce a reactive screen. With the OraQuick In-Home test, FDA puts the rate at roughly one false positive per 5,000 tests in people who do not have HIV.12 Rare is not never — but the system is built to catch exactly this, usually within days.

The waiting is hard. Two things help: tell one person you trust, and put the confirmatory appointment on the calendar so the wait has an end date. Community publications like POZ and TheBody carry first-person accounts of these days.

If the result is confirmed — what happens next, and how fast

A confirmed HIV diagnosis in 2026 is the beginning of treatment, not the beginning of decline — and the modern standard of care is unambiguous about speed. The federal HIV clinical guidelines recommend antiretroviral therapy for everyone living with HIV, both to reduce illness and death and to prevent transmission, and recommend initiating ART immediately — or as soon as possible — after diagnosis.16 CDC's Rapid ART Toolkit defines rapid ART as starting within 7 days of diagnosis or as soon as possible, consistent with the National HIV/AIDS Strategy target of ideally the same day.16

Some programs go further. CDC's toolkit describes an Immediate Start Model in which ART may begin before confirmatory testing is complete, with two serial rapid tests on the same day and a follow-up visit within 7 to 14 days as safeguards.16 That is how seriously the field now takes delay.

What rapid start buys is time to undetectable. In San Francisco's RAPID program, among 225 newly diagnosed people — more than half of whom started ART on the day of diagnosis — the median time from starting ART to viral suppression below 200 copies/mL was 41 days.16 Randomized trials in South Africa and Haiti found same-day initiation increased viral suppression at about one year.16 And maintaining plasma HIV RNA below 200 copies/mL prevents sexual transmission.16 That is the whole arc — from a test result to a life where you cannot pass HIV to a partner — and it now routinely takes weeks, not years.

A good first appointment includes baseline labs (CD4 count, viral load, resistance testing, kidney and liver function, hepatitis and STI screening), a conversation about which regimen fits your life, and a handoff to whatever helps you stay in care. If the clinic cannot start quickly, ask whether there is a rapid-start program nearby.

Post-exposure prophylaxis — the 72-hour window

If something happened in the last three days — a condom broke, a needle was shared, a sexual assault occurred, an occupational needlestick — this is the most time-sensitive information on this page. Post-exposure prophylaxis (PEP) is HIV medication taken after a possible exposure to stop HIV taking hold.

PEP must be started within 72 hours (3 days) of the exposure, ideally within 24; CDC's guidance is blunt that "every hour counts."14 It is a 28-day course of daily oral HIV medicines, effective when taken as prescribed though not 100% effective.14 PEP is for emergencies, not ongoing use — that is what PrEP is for.15

Where to get PEP tonight

Contact a provider immediately, or go to an emergency room or urgent care; HIV.gov's services locator lists PEP providers near you.15 Pharmacists can prescribe PEP directly in a growing list of states — Arkansas, California, Colorado, Illinois, Maine, Nevada, New Mexico, New York, North Carolina, Oregon, Utah, and Virginia.15 If the clinician in front of you is unsure, CDC runs a PEP Consultation Service at 1-888-448-4911.14

Cost should not stop you

Many insurance plans cover PEP, including Medicaid in many states, and manufacturers run patient assistance and co-payment assistance programs for people without coverage. Survivors of sexual assault may have PEP costs reimbursed through the Department of Justice–funded Office for Victims of Crime, and occupational exposures are usually covered by workers' compensation.15

Testing around PEP

You will have a baseline HIV test when you start PEP, and follow-up testing is recommended at 4 to 6 weeks and again at 3 months after the exposure.15 If exposures are ongoing rather than one-time, ask your provider about moving from PEP straight onto PrEP when the 28-day course finishes.15 That handoff is one of the highest-value moments in HIV prevention, and it is easy to miss if nobody raises it.

Testing while you're on PrEP — and one thing to know about self-tests

PrEP and HIV testing are permanently linked. Because starting PrEP with undiagnosed HIV can lead to drug resistance, testing is required before you start and continues on a regular schedule — generally every three months.9

Here is the detail that surprises people: HIV self-tests are usually not recommended for people taking PrEP. CDC explains that self-tests are less sensitive for recent HIV, so people on PrEP should keep testing quarterly through laboratory visits; home specimen collection kits, where a lab runs the assay, are sensitive enough and are an acceptable alternative.9 That is why Together TakeMeHome invites people on PrEP to order tests to give away rather than use themselves.10

Partners — notification without exposure

Telling partners is often the part people dread most. It is also the part where you have the most support. Partner services are free and provided through local health departments, and CDC describes three methods of notification:17

• Provider referral — the health department notifies your partners. CDC identifies this as best practice: more partners are successfully notified, and your name is not disclosed.
• Self-referral — you tell your partners yourself, on your own terms and timeline.
• Dual referral — you and a health department staff member tell partners together, for when you want to be present but not alone.

CDC "strongly recommends that all persons with newly diagnosed or reported HIV infection or early syphilis receive partner services with active health department involvement."17 Staff are trained to screen for the possibility of partner violence before any notification happens — if you have safety concerns about a specific partner, say so, and it will change how notification is handled.

There is also a low-friction option for anyone who wants a partner informed without a conversation they are not ready for: TellYourPartner.org, a free service that lets you anonymously text or email a partner about a possible STI exposure. Text notifications are always anonymous.18 CDC's guidance is pragmatic: anonymous notification via the internet "is considered better than no notification at all."4

If you are the partner receiving the news: get tested, and know that a negative test does not close the question immediately — because of the window period, retesting about three months later is generally advised.1 And if the exposure was within the last 72 hours, PEP is available to you tonight.14

Confidential versus anonymous testing

These two words get used interchangeably and mean different things. The difference matters if privacy is what has been keeping you from testing.

One thing that is not a trade-off any more: consent paperwork. CDC states that HIV screening should be voluntary and free from coercion, that specific signed consent is not recommended, and that general informed consent for medical care is sufficient.4 You may decline an HIV test — but you should not have to sign a special form to accept one.

Testing in pregnancy — the biggest prevention win in HIV

Perinatal HIV transmission is one of public health's clearest success stories, and every part of it depends on testing early enough to act. CDC's guidance is that all pregnant women in the United States should be tested for HIV at the first prenatal visit, even if tested before, as part of the routine prenatal panel using opt-out testing, and that partners of pregnant patients should be offered testing if their status is unknown.1919 The USPSTF's Grade A recommendation covers all pregnant persons, explicitly including those presenting in labor or at delivery with unknown status.6

Retesting in the third trimester — preferably before 36 weeks' gestation — is recommended for people with an increased likelihood of acquiring HIV during pregnancy: CDC's examples include people who inject drugs, who have an STI or a new or additional partner during pregnancy, whose partner is living with HIV, who are incarcerated, who live in areas with high rates of HIV, who receive care where HIV incidence is at least 1 per 1,000 women per year, or who have signs of acute HIV.19 CDC's 2006 recommendations went further, noting a second third-trimester test "is cost-effective even in areas of low HIV prevalence and may be considered for all pregnant women," and recommending it for jurisdictions with elevated incidence — a list that has included Florida.5

If someone arrives in labor untested or with unknown status, rapid HIV testing should be performed unless they decline — and if the rapid result is positive, antiretroviral therapy should be started without waiting for confirmatory testing.19 CDC's earlier recommendations add the operational detail: begin prophylaxis on a reactive rapid result, give infant prophylaxis ideally within 12 hours of birth, and provide preventive antibiotics at 4 to 6 weeks.5 People who received no prenatal care should be tested at delivery.19

Two things worth holding onto. Opt-out does not mean automatic: CDC's own language is that "no woman should be tested without her knowledge."5 And a positive test in pregnancy is not a crisis of your making — it is the moment the system can protect you and your baby, and modern treatment makes transmission to an infant rare when it starts in time.

Florida — where to test, and why it matters here

Florida carries one of the country's heaviest HIV burdens and one of its largest free-testing infrastructures. In 2022 the state identified 4,606 new HIV diagnoses.20 Florida's prevention program reports more than 1,600 publicly funded and registered HIV testing sites statewide — county health departments, community-based organizations, jails, hospitals, community health centers, mobile testing units, STD clinics, and outreach events.21 The Department of Health also lets residents find testing locations and order a free at-home HIV testing kit through its HIV/AIDS program pages.20

Florida also staffs live consultation lines most residents have never heard of: a Perinatal HIV/AIDS line at 888-448-8765, a Post-Exposure Prophylaxis line at 888-448-4911, general clinical questions at 800-933-3413, and a Prenatal HIV line at 800-451-BABY (2229).20 If you are a Floridian who thinks an exposure happened last night, that PEP number is the fastest path to an informed answer.

What to do this week

1. If a possible exposure happened in the last 72 hours, stop reading and seek PEP — emergency room, urgent care, your provider, or a pharmacist where that is allowed. Every hour counts, and the window closes at 72 hours.14
2. If you cannot remember your last HIV test, get one — CDC recommends at least one test for everyone 13 to 64 as routine care.1
3. Match the test to your timeline. Under 18 days since a specific exposure, ask about a NAT; 18 to 45 days, a laboratory antigen/antibody test from a vein; past 90 days, any test type is conclusive for that exposure.1
4. Order the free two-pack from Together TakeMeHome — one for you, one to share.10
5. If you are on PrEP, keep the quarterly lab appointment instead of substituting a self-test, and give your mailed tests to someone else.9
6. If you got a preliminary positive, book the confirmatory test immediately, keep taking your current medications, and tell one person you trust.5
7. If a diagnosis is confirmed, ask for rapid ART — same day if possible, within 7 days as the standard — and accept the case-management handoff.16
8. If you are pregnant or planning to be, confirm HIV testing was in your first prenatal panel and ask whether third-trimester retesting applies to you.19
9. For partner notification, ask your health department about provider referral — your name is not disclosed — or use TellYourPartner.org for an anonymous text.1718